Test Price
900 AED✅ Home Collection Available
Epstein-Barr Virus (EBV) Qualitative PCR Test in Dubai | 900 AED | DHA Licensed Lab
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited qPCR Processing.
- Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Complimentary post-test clinical interpretation by a licensed General Practitioner via telephone.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- DHA License: Facility License No. 1143 — Dubai Healthcare City, fully compliant with Dubai Health Authority standards.
Test Overview & Methodology
The Epstein-Barr Virus (EBV) Qualitative PCR test is a molecular diagnostic assay that detects the presence of EBV DNA in whole blood or cerebrospinal fluid (CSF) using real-time polymerase chain reaction (qPCR). This test is the gold standard for confirming active EBV infection, monitoring viral reactivation in immunocompromised patients, and distinguishing primary infection from past exposure. Results are reported as detected or not detected, with semi-quantitative cycle threshold (Ct) values provided for clinical correlation.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Qualitative detection with Ct values plus dual-target probe confirmation | Single-target qualitative or serology-based antibody testing |
| Methodology | Real-Time PCR (qPCR) — ISO 15189:2022 validated, DHA compliant | Conventional PCR or EBV serology (VCA-IgM, VCA-IgG, EA-IgG) |
| Turnaround Time | 24 to 48 hours from sample receipt at laboratory | 3 to 7 working days |
| Sample Requirements | 3 mL whole blood (EDTA) or 2 mL CSF – strict cold-chain required | Serum for serology, no cold-chain specification |
Cold-chain transport maintained at 2-8°C throughout. Sample stability: whole blood 48 hours, CSF 24 hours from collection.
Physician Insight & Safety Protocols
"A positive EBV qualitative PCR result confirms the presence of viral DNA, which may indicate acute primary infection, reactivation, or viral shedding in the context of immunosuppression. Clinical correlation with symptoms, serological markers, and haematological findings is essential for accurate interpretation. Patients should never self-diagnose or self-treat based on PCR results alone; always consult with your prescribing physician for a comprehensive clinical assessment."
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Advisory & Medication Guidelines
Do not discontinue any prescribed antiviral or immunosuppressive medication without consulting your doctor. Antiviral agents such as acyclovir or valacyclovir, and immunomodulators like corticosteroids, can influence viral load dynamics and may affect the clinical interpretation of PCR results. Always inform your physician of all medications you are currently taking prior to sample collection.
Exclusion Criteria & Red Flags
- Inability to provide minimum sample volume (3 mL whole blood EDTA / 2 mL CSF).
- Samples that are clotted, haemolysed, or frozen – DO NOT FREEZE specimens.
- Patients with active severe bleeding or haemodynamic instability — hospital-based collection only.
- Emergency Red Flags: Sudden high fever (greater than 39°C), severe headache, neck stiffness, confusion, photophobia, or seizures — seek emergency medical care immediately without waiting for test results.
Patient FAQ & Clinical Guidance
1. What does a positive EBV qualitative PCR result mean?
A positive result indicates that EBV DNA was detected in your blood or CSF sample. This may represent an acute primary infection (such as infectious mononucleosis), reactivation of a latent virus, or viral shedding related to immunosuppression. Your doctor will correlate this result with your symptoms, blood counts, and serology to determine the clinical significance.
2. How is EBV qualitative PCR different from the EBV antibody test?
PCR directly detects the virus's genetic material, confirming active viral presence with high sensitivity and specificity. Serology tests measure antibodies the immune system produces against EBV and can only infer past or current infection indirectly. PCR is particularly valuable in immunocompromised patients who may not mount a detectable antibody response, and it can detect infection earlier than seroconversion.
3. What preparation is needed before the EBV PCR test?
No special preparation such as fasting is required. You may eat and drink normally. However, do not stop taking any prescribed medications (including antivirals or immunosuppressants) unless explicitly directed by your physician. Inform the phlebotomist if you have a history of bleeding disorders or are on anticoagulation therapy.
4. Are there any risks or side effects from the EBV PCR test?
The test carries minimal risk. For a blood draw, you may experience slight bruising, discomfort, or rarely, local infection at the needle site. CSF collection via lumbar puncture is performed only in a hospital setting by a trained physician and carries a small risk of headache, infection, or bleeding. Discuss all risks with your healthcare provider before proceeding.
5. How quickly will I receive my results?
Results are typically available within 24 to 48 hours after the laboratory receives your sample. You will receive your report via email or WhatsApp, and a complimentary telephone consultation with Dr. Ajay Singh is included to help you understand the clinical implications of your result.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Protection
DNA Labs UAE operates under the strictest data privacy and security frameworks mandated by UAE federal law. All patient health information is handled in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the collection, processing, storage, and transfer of personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating electronic health records and telemedicine communications.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — ensuring patient consent, clinical safety, and accountability in diagnostic procedures.
All laboratory data is encrypted in transit and at rest, accessible only to authorised clinical personnel, and retained for the duration required by UAE health regulations. Results are shared exclusively with the patient and their referring physician through secure channels.
Clinical & Logistical Metadata
| Test Name | Epstein-Barr Virus (EBV) Qualitative PCR |
| Price (AED) | 900 AED |
| Turnaround Time | 24 to 48 hours from sample receipt |
| Sample Type / Matrix | Whole blood (EDTA) or cerebrospinal fluid (CSF) — Hospital Extraction Only. Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Real-Time Polymerase Chain Reaction (qPCR) — ISO 15189:2022 accredited, dual-target probe detection |
| ICD-10-CM Code | B27.90 (Infectious mononucleosis, unspecified) / B27.0 (Gammaherpesviral mononucleosis) |
| LOINC Code | 30010-1 (Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection) / 88592-2 (Epstein Barr virus DNA [Presence] in CSF by NAA with probe detection) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians